JCR Journal of Clinical Rheumatology · 2012 · 75 citations · 15 references
MedicineDermatologyImmunologyDermatopathologyImmunopathologyRheumatologyInflammatory ArthritisInflammatory DermatosesInflammatory Disease PathologyInflammatory Skin DiseasesInflammatory Skin DisordersAxial DiseaseInflammatory SpondyloarthritisPyoderma GangrenosumPyogenic ArthritisPyogenic InflammationRheumatic InflammationTumor Necrosis Factor Therapy
We report the case of a patient with a simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. This condition differs from both the PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis) syndrome, in which arthritis is absent, and the PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome, in which suppurative hidradenitis is lacking. Our patient failed to respond to etanercept therapy, whereas all dermatologic and rheumatic manifestations completely regressed following infliximab infusion. We therefore propose that simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and seronegative spondyloarthritis might represent a distinct syndrome that could be termed the PASS syndrome. Tumor necrosis factor α therapies seem to play selective roles.
15
Joachim Sieper, D. van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 642 citations · Full text
Medicine, Rehabilitation Medicine, Musculoskeletal Medicine +11
Annika Grant, Tayler Gonzalez, Michael O. Montgomery et al. · Journal of the American Academy of Dermatology · 2010 · 412 citations